Related Experiment Video
Updated: Feb 15, 2026

In vivo Imaging and Therapeutic Treatments in an Orthotopic Mouse Model of Ovarian Cancer
Published on: August 17, 2010
The latest animal models of ovarian cancer for novel drug discovery
Elizabeth Magnotti1, Wayne A Marasco1,2
1a Department of Cancer Immunology and Virology , Dana-Farber Cancer Institute , Boston , MA , USA.
Introduction:
Epithelial ovarian cancer is a heterogeneous disease classified into five subtypes, each with a different molecular profile. Most cases of ovarian cancer are diagnosed after metastasis of the primary tumor and are resistant to traditional platinum-based chemotherapeutics. Mouse models of ovarian cancer have been utilized to discern ovarian cancer tumorigenesis and the tumor's response to therapeutics. Areas covered: The authors provide a review of mouse models currently employed to understand ovarian cancer. This article focuses on advances in the development of orthotopic and patient-derived tumor xenograft (PDX) mouse models of ovarian cancer and discusses current humanized mouse models of ovarian cancer. Expert opinion: The authors suggest that humanized mouse models of ovarian cancer will provide new insight into the role of the human immune system in combating and augmenting ovarian cancer and aid in the development of novel therapeutics. Development of humanized mouse models will take advantage of the NSG and NSG-SGM3 strains of mice as well as new strains that are actively being derived.
Insights
Researchers reviewed mouse models for studying epithelial ovarian cancer, focusing on advancements in orthotopic and patient-derived xenograft models. Humanized models show promise for understanding the immune system
Area of Science:
- Oncology
- Immunology
- Animal Models
Background:
- Epithelial ovarian cancer is a complex disease with diverse subtypes.
- Late-stage diagnosis and platinum resistance are common challenges.
- Mouse models are crucial for understanding ovarian cancer development and treatment response.
Purpose of the Study:
- To review current mouse models used in ovarian cancer research.
- To highlight advances in orthotopic and patient-derived xenograft (PDX) models.
- To discuss the potential of humanized mouse models in ovarian cancer research.
Main Methods:
- Review of existing literature on ovarian cancer mouse models.
- Focus on orthotopic and PDX model development.
- Discussion of humanized mouse models, including NSG and NSG-SGM3 strains.
Main Results:
- Orthotopic and PDX models offer valuable insights into ovarian cancer.
- Humanized mouse models are emerging as a significant tool.
- Advances in mouse strains are facilitating new research avenues.
Conclusions:
- Humanized mouse models are expected to illuminate the role of the human immune system in ovarian cancer.
- These models will aid in developing novel therapeutic strategies.
- Continued development of advanced mouse models is essential for progress in ovarian cancer research.
More Related Videos
Related Concept Videos
Drug Discovery: Overview
Ovarian Cycle
Mouse Models of Cancer Study
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
Tonicity in Animals
Tonicity in Animals
Animal Mitochondrial Genetics

